|
|
|
| home > white papers > Spotlight on Quality in Study Startup - Oracle Health Sciences |
|
|
 WHITE PAPERS |
|
|
Oracle Health Sciences
|
475 Sansome Street, #15 | San Francisco, CA 94111
|
|
|
Spotlight on Quality in Study Startup
|
|
This white paper addresses the growing interest in quality in clinical
trial execution and how workflows play an essential role by building in
the steps needed to comply with TMF guidelines, reducing downstream
problems. This proactive strategy limits issues caused by siloes,
yielding process improvements measurable by performance metrics.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
GSK Announces Positive Pivotal Phase III Data for its Respiratory Syncytial Virus (RSV) Vaccine Candidate for Older Adults
GSK plc (LSE/NYSE: GSK) today announced positive headline results
from a pre-specified efficacy interim analysis of the AReSVi 006 phase
III trial. The interim analysis was reviewed by an Independent Data
Monitoring Committee, and the primary endpoint was exceeded with no
unexpected safety concerns observed. AReSVi 006 is a phase III trial
investigating GSK’s respiratory syncytial virus (RSV) vaccine candidate
for adults aged 60 years and above.
More info >> |
|
 |
White Papers |
 |
|
What Your Clinical Study Design Reveals About Your Clinical Packaging Needs
PCI Pharma Services
As the cost and complexities of drug development increase, so do the challenges of global clinical trials. Today’s sponsors must be able to manage and coordinate multiple resources, processes, and locations with speed and accuracy to design effective and efficient clinical trials. Securing a stable supply chain to deal with the uncertainties of clinical trials is critical. One misstep can have a profound impact not only on the cost and time of your trial but also on its overall success.
More info >> |
|
|
|
